PCDHB6: A Protein Involved in Cell Signaling as A Potential Drug Target

Target Name: PCDHB6

NCBI ID: G56130

PCDHB6

PCDHB6: A Protein Involved in Cell Signaling as A Potential Drug Target

PCDHB6 (Protocadherin Beta 6) is a protein that is expressed in various tissues throughout the body. It is a member of the protocadherin family, which is a group of transmembrane proteins that are involved in cell-cell adhesion. PCDHB6 is one of the proteins that belong to the beta 6 subfamily of protocadherins.

PCDHB6 is known for its role in cell signaling, particularly in the regulation of cell proliferation and differentiation. It is a key regulator of the Wnt/FGF signaling pathway, which is involved in the development and maintenance of tissues and organs.

PCDHB6 is also a potential drug target and biomarker. Its role in cell signaling makes it an attractive target for small molecule inhibitors, which could be used to treat a variety of diseases.

Targeting PCDHB6

PCDHB6 is a protein that is expressed in various tissues throughout the body, including epithelial, neural, and cardiac cells. It is involved in the regulation of cell signaling, including the regulation of cell proliferation and differentiation.

One of the ways that PCDHB6 is involved in cell signaling is through its role in the regulation of the Wnt/FGF signaling pathway. This pathway is involved in the development and maintenance of tissues and organs, and it is a key regulator of the PCDHB6 gene.

PCDHB6 is a key regulator of the Wnt/FGF signaling pathway by controlling the activity of the transcription factor SMAD. SMAD is a protein that is involved in the regulation of gene expression, and it is a direct target of PCDHB6.

PCDHB6 interacts with SMAD to regulate the activity of the transcription factor, which is involved in the regulation of gene expression. This interaction between PCDHB6 and SMAD is important for the regulation of cell signaling and the development and maintenance of tissues and organs.

Another way that PCDHB6 is involved in cell signaling is through its role in the regulation of the TGF-β signaling pathway. This pathway is involved in the regulation of cell growth and differentiation, and it is a key regulator of the PCDHB6 gene.

PCDHB6 is a key regulator of the TGF-β signaling pathway by controlling the activity of the transcription factor, which is involved in the regulation of gene expression. This interaction between PCDHB6 and TGF-β is important for the regulation of cell signaling and the development and maintenance of tissues and organs.

PCDHB6 as a drug target

PCDHB6 is a protein that is involved in cell signaling, and as such, it is an attractive target for small molecule inhibitors. The ability of PCDHB6 to regulate cell signaling makes it an attractive target for the development of drugs that can treat a variety of diseases.

One of the potential benefits of targeting PCDHB6 is that it can be used to treat a variety of diseases that are caused by the regulation of cell signaling. For example, PCDHB6 is involved in the regulation of cell proliferation and differentiation, which makes it an attractive target for the treatment of diseases that are caused by the regulation of these processes, such as cancer.

Another potential benefit of targeting PCDHB6 is that it can be used to treat a variety of other diseases, including genetic and metabolic diseases. For example, PCDHB6 is involved in the regulation of cell signaling in the development and maintenance of tissues and organs, which makes it an attractive target for the treatment of diseases that are caused by the regulation

Protein Name: Protocadherin Beta 6

Functions: Calcium-dependent cell-adhesion protein involved in cells self-recognition and non-self discrimination. Thereby, it is involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHB6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets